首页> 外文会议>American College of Veterinary Surgeons Surgery Summit >DEVELOPING ADIPOSE-DERIVED MESENCHYMAL STEM CELL THERAPIES FOR CLINICAL USE IN OSTEOARTHRITIS
【24h】

DEVELOPING ADIPOSE-DERIVED MESENCHYMAL STEM CELL THERAPIES FOR CLINICAL USE IN OSTEOARTHRITIS

机译:开发脂肪衍生的间充质干细胞疗法,用于骨关节炎的临床应用

获取原文

摘要

Autologous, adipose derived mesenchymal stem cell therapy has growingevidence for clinical effect in the treatment of osteoarthritis in canines.Allogeneic, adipose derived mesenchymal stem cell therapy for the treatment ofosteoarthritis in canines has many potential advantages, provided critical,objective evaluations for safety and efficacy continue to be generated.Standardization of stem cell products will provide the cleanest data for analysisand comparison of clinical and biomolecular effects on a challenging and diversedisease process.
机译:自体,脂肪衍生的间充质干细胞疗法在治疗患者中治疗骨关节炎的临床效果生长。富含脂肪衍生的间充质干细胞疗法在讨论者中进行治疗,提供了许多潜在的优势,提供了批判性和疗效的临界,客观评估持续存在 待产生。干细胞产物的标准化将提供最干净的数据,用于分析和临床和生物分子对挑战性和多元化酶的比较进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号